Early Biomarkers and Hearing Impairments in Patients with Neonatal Hypoxic–Ischemic Encephalopathy
Identifying biomarkers for hearing impairments (HIs) in patients with neonatal hypoxic–ischemic encephalopathy (HIE), to initialize early hearing habilitation, is crucial. Seventy-eight neonates with HIE were divided into the following two groups: those with HIs and those without HIs. We compared th...
Guardado en:
Autores principales: | Da-Yang Chen, Inn-Chi Lee, Xing-An Wang, Swee-Hee Wong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4a585bb73694d12a7b9a23080d358d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment device for neonatal birth asphyxia related Hypoxic Ischemic Encephalopathy
por: Rediet Zewdie, et al.
Publicado: (2021) -
Expression levels of the BAK1 and BCL2 genes highlight the role of apoptosis in age-related hearing impairment
por: Falah M, et al.
Publicado: (2016) -
A High Risk of Missing Congenital Cytomegalovirus-Associated Hearing Loss through Newborn Hearing Screening in Japan
por: Shujiro Bando Minami, et al.
Publicado: (2021) -
Etiologies of Childhood Hearing Impairment in Schools for the Deaf in Mali
por: Abdoulaye Yalcouyé, et al.
Publicado: (2021) -
Effects of Hearing Impairment, Quality of Life and Pain on Depressive Symptoms in Elderly People: A Cross-Sectional Study
por: Weiyi Sun, et al.
Publicado: (2021)